pediatr
communityacquir
pneumonia
cap
lead
caus
hospit
admiss
li
tancredi
grijalva
et
al
grijalva
et
al
potenti
wide
rang
bacteri
viral
fungal
mycobacteri
etiolog
erlichman
et
al
larg
multisit
studi
children
hospit
cap
radiograph
evid
pneumonia
standardofcar
test
identifi
viral
infect
patient
bacteri
infect
patient
viral
bacteri
infect
patient
jain
et
al
current
pediatr
cap
guidelin
infecti
diseas
societi
america
idsa
pediatr
infecti
diseas
societi
pid
recommend
blood
cultur
viral
test
hospit
patient
moder
sever
communityacquir
complic
pneumonia
order
identifi
pathogen
recommend
empir
treatment
includ
thirdgener
cephalosporin
patient
evid
empyema
addit
vancomycin
clindamycin
clinic
laboratori
imag
characterist
consist
methicillinresist
staphylococcu
aureu
bradley
et
al
mrsa
infect
case
cultur
eg
blood
respiratori
pleural
fluid
neg
physician
reli
epidemiolog
clinic
featur
predict
like
infecti
organ
guid
empir
antibiot
select
challeng
causal
organ
overlap
clinic
radiograph
laboratori
featur
andor
atyp
present
addit
clinic
cours
complic
pneumonia
often
lengthi
despit
presenc
appropri
antimicrobi
coverag
breuer
et
al
absenc
identifi
pathogen
children
seriou
infect
may
treat
broadspectrum
antibiot
prolong
cours
due
concern
mrsa
dna
sequenc
cellfre
plasma
de
vlaminck
et
al
long
et
al
hong
et
al
allow
detect
pathogen
dna
deriv
bloodstream
infect
deeper
bodi
site
includ
case
antibiot
pretreat
prior
cultur
fastidi
difficulttocultur
organ
abril
et
al
case
seri
reflect
institut
experi
appli
diagnost
microbiolog
infecti
diseas
cellfre
sequenc
technolog
new
commerci
avail
test
whose
applic
extens
studi
current
retrospect
seri
children
cap
perform
assess
clinic
impact
test
compar
tradit
microbiolog
method
retrospect
chart
review
approv
human
research
protect
program
univers
california
san
diego
hrp
evalu
use
cellfre
plasma
nextgener
sequenc
cfpng
plasma
test
manag
children
infect
june
januari
inclus
criteria
includ
previous
healthi
children
cap
complic
cap
defin
idsapid
guidelin
cfpng
order
discharg
prior
februari
cfpng
restrict
test
order
pediatr
infecti
diseas
faculti
electron
medic
record
prospect
standard
criteria
delin
obtain
cfpng
rather
discret
pediatr
infecti
diseas
faculti
children
chronic
complex
underli
medic
diseas
exclud
ie
underli
oncolog
genet
chronic
ill
andor
use
immunomodulatori
medic
chart
review
perform
use
electron
medic
record
incorpor
redcap
databas
harri
et
al
peripher
blood
sampl
collect
bd
vacutain
plasma
prepar
tube
ppt
tube
becton
dickson
compani
franklin
lake
nj
centrifug
sent
kariu
laboratori
redwood
citi
ca
cfpng
de
vlaminck
et
al
cellfre
dna
extract
plasma
magnet
beadbas
method
omega
biotek
norcross
ga
dna
librari
construct
use
modifi
ovat
system
librari
kit
nugen
san
carlo
ca
neg
bufferonli
control
posit
control
consist
healthi
patient
plasma
addit
known
mixtur
microbi
dna
fragment
process
parallel
sampl
sequenc
illumina
nextseq
blood
urin
respiratori
pleural
bacteri
fungal
mycobacteri
cultur
well
multiplex
pcr
eplex
respiratori
pathogen
panel
detect
viral
pathogen
obtain
discret
treat
physician
sampl
cultur
cfpng
tempor
match
acquisit
avail
standard
care
test
data
includ
obtain
within
h
cfpng
treat
physician
determin
antimicrobi
therapi
pediatr
infecti
diseas
faculti
assess
effect
cfpng
test
select
antibiot
therapi
subsequ
procedur
length
stay
primari
sequenc
output
file
process
use
gener
demultiplex
sequenc
read
file
read
filter
base
sequenc
qualiti
trim
base
partial
full
adapt
sequenc
sequenc
align
remain
read
perform
kariu
human
syntheticmolecul
refer
use
langmead
salzberg
sequenc
read
exhibit
align
human
synthet
molecul
refer
collect
filter
analysi
remain
read
align
kariu
proprietari
microorgan
refer
databas
use
ncbiblast
version
determin
whether
level
observ
sampl
exceed
expect
origin
environ
alon
poisson
model
parameter
estim
background
abund
appli
taxa
reject
null
hypothesi
high
signific
level
report
includ
downstream
analys
entir
process
dna
extract
analysi
typic
complet
within
h
review
period
total
children
admit
hospit
cap
cfpng
test
obtain
discret
pediatr
infecti
diseas
attend
physician
children
exclud
due
diagnos
underli
genet
disord
due
chronic
comorbid
condit
patient
demograph
remain
cohort
demonstr
averag
age
year
male
gender
tabl
averag
length
hospit
stay
day
reflect
fact
cfpng
tend
request
case
complic
pneumonia
total
children
diagnos
complic
cap
pneumonia
pleural
effus
empyema
requir
admiss
pediatr
intens
care
unit
picu
nine
children
treat
thoracoscopi
parapneumon
effus
empyema
children
requir
surgic
intervent
videoassist
thoracoscop
surgeri
tabl
patient
posit
blood
cultur
time
admiss
cultur
yield
streptococcu
pneumonia
cfpng
also
posit
case
pneumococci
identifi
addit
case
cfpng
fig
tabl
respiratori
cultur
obtain
intub
children
endotrach
aspir
yield
put
causal
organ
studi
popul
posit
cultur
patient
respiratori
sampl
patient
cultur
concord
cfpng
diagnost
test
patient
identifi
pneumonia
ett
blood
cultur
well
cfpng
patient
posit
respiratori
cultur
patient
identifi
pseudomona
aeruginosa
sputum
neg
cfpng
patient
retrospect
studi
cfpng
identifi
children
bacteri
infecti
etiolog
could
potenti
explain
acut
pneumonia
oppos
tradit
cultur
method
sinc
introduct
pneumococc
conjug
vaccin
follow
decreas
pediatr
hospit
admiss
pneumococc
pneumonia
increas
staphylococc
pneumonia
unspecifi
empyema
time
cfpng
blood
drawn
fax
result
scan
electron
medic
record
includ
laboratori
process
ship
time
kariu
inc
time
get
result
emr
result
fax
grijalva
et
al
although
increas
staphylococc
pneumonia
may
decreas
mrsa
et
al
prior
introduct
pneumococc
conjug
vaccin
emerg
communityacquir
mrsa
mani
physician
felt
confid
manag
cap
base
presum
diagnosi
pneumococc
streptococc
pneumonia
children
admit
cap
howev
given
chang
epidemiolog
landscap
pediatr
cap
mani
physician
less
confid
diagnosi
fulli
suscept
pneumonia
absenc
posit
cultur
therefor
empir
antibiot
coverag
broaden
includ
aureu
multidrugresist
pneumococcu
consensu
guidelin
provid
recommend
treatment
children
sever
cap
complic
cap
pauciti
strong
prospect
data
support
high
level
evid
tailor
treatment
hospit
children
cultureneg
cap
fontela
et
al
lastli
high
preval
cap
patient
antibiot
exposur
cohort
prior
relev
cultur
sampl
includ
blood
cultur
reduc
sensit
cultur
pathogen
detect
use
convent
method
use
cfpng
help
address
issu
identifi
infecti
etiolog
children
even
standard
microbiolog
cultur
neg
howev
lack
rigor
data
regard
sensit
specif
cfpng
left
clinician
minim
inform
determin
would
benefit
cfpng
similar
previou
studi
lin
et
al
krenk
et
al
found
yield
blood
cultur
pleural
effus
cultur
low
possibl
secondari
antibiot
pretreat
interest
note
complet
concord
cfpng
tradit
culturevir
pcr
see
tabl
import
challeng
applic
novel
technolog
sinc
cfpng
test
detect
rna
virus
concord
cfpng
respiratori
pcr
test
also
local
sampl
tradit
ett
cultur
could
explain
respiratori
cultur
agreement
cfpng
sinc
respiratori
sampl
collect
upper
airway
may
repres
infect
lung
base
upon
detect
organ
often
streptococcu
pneumonia
consist
clinic
present
site
infect
area
high
blood
flow
lung
lead
increas
shed
pathogen
dna
blood
seem
reason
suggest
cfpng
may
better
reflect
natur
pulmonari
infect
sampl
obtain
upper
airway
rigor
studi
requir
delin
accuraci
cfpng
versu
tradit
cultur
cfpng
may
also
present
challeng
infecti
diseas
specialist
organ
common
pathogen
parvimona
micra
veillonella
dispar
identifi
critic
ill
patient
combin
potenti
pathogen
bacteria
isol
cfpng
signal
suggest
coinfect
bacteri
presenc
anoth
part
bodi
eg
oral
flora
patient
gingiv
pathogen
perhap
common
previous
thought
technolog
becom
broadli
accept
mani
question
care
examin
direct
result
cfpng
antibiot
select
narrow
children
studi
popul
betalactam
rather
continu
lincosamid
glycopeptid
treat
infecti
diseas
clinician
believ
identif
plausibl
organ
broad
coverag
longer
need
importantli
none
children
treat
narrow
antimicrobi
therapi
base
cfpng
result
readmit
late
complic
cap
could
attribut
inappropri
antibiot
therapi
also
note
howev
neg
predict
valu
test
fulli
character
review
address
proof
concept
clinic
applic
cfpng
cap
children
compar
cfpng
establish
diagnost
test
pathogenspecif
bacteri
realtim
pcr
howev
prospect
compar
studi
would
help
differenti
role
cfpng
context
avail
test
clinic
practic
retrospect
studi
numer
limit
broad
applic
find
first
studi
limit
scope
given
small
patient
number
uncontrol
natur
decis
consult
infecti
diseas
servic
consult
order
cfpng
test
although
data
reflect
realworld
experi
children
cap
select
cfpng
evalu
repres
sever
ill
patient
popul
demonstr
high
rate
picu
admiss
prolong
hospit
predomin
complic
cap
empyema
andor
parapneumon
effus
averag
time
cfpng
result
day
although
possibl
time
may
decreas
effici
transport
process
analysi
improv
overal
data
suggest
cfpng
conjunct
standard
cultur
techniqu
may
significantli
increas
diagnost
yield
facilit
antibiot
select
sever
cap
supplementari
data
articl
found
onlin
http
doi
